Arcadia Biosciences, Inc. (NASDAQ:RKDA – Get Free Report) was the recipient of a significant increase in short interest in May. As of May 29th, there was short interest totaling 411,143 shares, an increase of 4,427.0% from the May 14th total of 9,082 shares. Based on an average daily trading volume, of 6,750,071 shares, the days-to-cover ratio is presently 0.1 days. Approximately 21.8% of the shares of the stock are short sold.
Arcadia Biosciences Trading Down 0.5%
Shares of RKDA stock traded down $0.00 during mid-day trading on Tuesday, reaching $0.92. The stock had a trading volume of 67,311 shares, compared to its average volume of 608,863. Arcadia Biosciences has a 12-month low of $0.80 and a 12-month high of $6.71. The company has a market cap of $1.90 million, a P/E ratio of -0.16 and a beta of 0.51. The business has a 50-day simple moving average of $1.12 and a 200 day simple moving average of $2.00.
Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) last announced its quarterly earnings results on Thursday, May 14th. The basic materials company reported ($2.11) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.80) by ($1.31). Arcadia Biosciences had a negative net margin of 195.94% and a negative return on equity of 113.73%. The firm had revenue of $1.10 million during the quarter, compared to analysts’ expectations of $1.60 million.
Analyst Ratings Changes
Get Our Latest Stock Analysis on RKDA
About Arcadia Biosciences
Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.
Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.
Read More
- Five stocks we like better than Arcadia Biosciences
- The Bank of Mom and Dad Is Booming—3 Stocks to Watch
- Corning Is Paving AI’s Future With Glass
- Why’s Amazon Suddenly Lagging the S&P 500, and Is It a Warning?
- Crypto Winter Is Here: 3 Stocks To Put On Ice This Summer
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
